hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 21:36:18 - browse：639

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： STAT wants to know your pick for a great summer read or listen

WSS

Why scientists need input from humanists on sensitive research

Medicare coverage of Wegovy, once blocked, now looks possible

RaDonda Vaught links Vanderbilt hospital issues to patient death

Hubble vs. James Webb telescope images: See the difference

Use doctors trained outside the U.S. to ease the physician shortage

Beware reading your test results before your doctor does

entertainment

hotspot

leisure time

Activists slam private health insurers over coverage restrictions

Canadians with cystic fibrosis outlive Americans by a decade

How one medical school became remarkably diverse

EPA limits use of carcinogenic gas for sterilizing medical devices

United colonoscopy coverage change 'may cost lives,' doctors say

Why scientists need input from humanists on sensitive research

Walensky prepares to leave CDC — and Congress — behind

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Why depression after traumatic brain injury is distinct

hotspot

UCLA team creates talking throat patch for voice disorders

Ebola: Gilead Sciences antiviral shows promise as new treatment

HHS secretary Becerra pressed on Change HealthCare cyberattack

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

EPA limits use of carcinogenic gas for sterilizing medical devices

Crowdfunding for unproven stem cell procedures spreads misinformation

focus

explore

entertainment

leisure time